Plain-English translation of NCT07263061 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how quickly a protein called albumin recovers in your blood after major surgery on your liver, pancreas, or bile ducts. This recovery pattern may help doctors predict which patients will have complications after surgery and which will recover smoothly. By understanding this better, doctors hope to identify patients who need extra support or monitoring early on.
Major liver, pancreas, and bile duct surgeries carry a real risk of complications after the operation. Currently, doctors don't have a simple way to predict early which patients will struggle and which will do well. This study aims to fill that gap by finding out if tracking how fast this blood protein recovers can serve as an early warning sign.
You likely qualify if…
You likely don't qualify if…
This is mainly an observational study, meaning researchers will track your blood albumin levels before and after your surgery—something that's already part of standard surgical care. For the prospective arm, you'll have routine blood tests done as part of your normal post-surgery follow-up. For the retrospective arm, researchers will review your existing medical records from surgery. The study is enrolling up to 1,000 patients total.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
India